Proteomic profiling of high purity extracellular vesicle subtypes from megakaryoblastic leukemia cells provides insights into myeloproliferative neoplasm biology

Abstract

Aim: Extracellular vesicles (EVs) are emerging as important mediators in myeloproliferative neoplasms (MPNs), but the characteristics of distinct EV subtypes remain unclear. This study aimed to characterize the molecular heterogeneity of MEG-01-derived large EVs (lEVs) and small EVs (sEVs).

Methods: lEVs and sEVs were isolated from MEG-01 cell culture medium by differential centrifugation followed by density gradient ultracentrifugation. EVs were characterized by transmission electron microscopy, nanoparticle tracking analysis, immunoblotting, and on-bead flow cytometry. Quantitative proteomic analysis was performed to compare the protein cargo of lEVs and sEVs, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.

Results: Density gradient purification yielded high purity of lEV and sEV with distinct size, morphologies, and protein compositions. On-bead flow cytometry enabled efficient profiling of EV surface markers. Proteomic analysis revealed a shared core proteome between lEVs and sEVs, together with subtype specific protein signatures. Enrichment analyses indicated distinct molecular characteristics of the two EV populations, with sEVs showing enrichment of proteins associated with RNA-related processes and vesicle-mediated transport, whereas lEVs were enriched in proteins related to cytoskeletal organization and metabolism.

Conclusion: MEG-01 derived lEVs and sEVs comprise molecularly distinct subpopulations with shared and subtype specific protein cargo. The workflow established in this study provides a robust platform for high purity EV isolation and characterization, and offers insights into MEG-01 EV heterogeneity relevant to megakaryocyte biology and MPN research.

Keywords

MEG-01 / extracellular vesicles / subtypes / proteomics / myeloproliferative neoplasm

References

[1] Mejía-Ochoa M,Acevedo Toro PA,Cardona-Arias JA. Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000-2018 BMC Cancer 2019 19 590 PMC6580484

[2] Baumeister J,Chatain N,Sofias AM,Lammers T,Koschmieder S. Progression of myeloproliferative neoplasms (MPN): diagnostic and therapeutic perspectives Cells 2021 10 3551 PMC8700229

[3] Raposo G,Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends J Cell Biol 2013 200 373 83 PMC3575529

[4] Zomer A,Steenbeek SC,Maynard C,van Rheenen J. Studying extracellular vesicle transfer by a Cre-loxP method Nat Protoc 2016 11 87 101

[5] Rufino-Ramos D,Leandro K,Perdigão PRL.et al. Extracellular communication between brain cells through functional transfer of Cre mRNA mediated by extracellular vesicles Mol Ther 2023 31 2220 39 PMC10362460

[6] Boyiadzis M,Whiteside TL. The emerging roles of tumor-derived exosomes in hematological malignancies Leukemia 2017 31 1259 68

[7] Catani L,Cavo M,Palandri F. The power of extracellular vesicles in myeloproliferative neoplasms: “crafting” a microenvironment that matters Cells 2021 10 2316 PMC8464728

[8] Zarà M,Guidetti GF,Camera M.et al. Biology and role of extracellular vesicles (EVs) in the pathogenesis of thrombosis Int J Mol Sci 2019 20 2840 PMC6600675

[9] Jones CL. Studies on a human megakaryocytic cell line: activation and mitogen release. University of Cincinnati, 1989. Available from https://www.proquest.com/docview/303690970?pq-origsite=gscholar&fromopenview=true&sourcetype=Dissertations%20&%20Theses. [accessed 20 July 2026]

[10] Persson KM,Kneller PV,Livingston MW,Bush LM,Deans TL. High-throughput production of platelet-like particles Methods Mol Biol 2021 2258 273 83 PMC9677565

[11] Zhang X,Borg EGF,Liaci AM,Vos HR,Stoorvogel W. A novel three step protocol to isolate extracellular vesicles from plasma or cell culture medium with both high yield and purity J Extracell Vesicles 2020 9 1791450 PMC7480457

[12] Cox J,Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat Biotechnol 2008 26 1367 72

[13] Shah AD,Goode RJA,Huang C,Powell DR,Schittenhelm RB. LFQ-Analyst: an easy-to-use interactive web platform to analyze and visualize label-free proteomics data preprocessed with MaxQuant J Proteome Res 2020 19 204 11

[14] Eustes AS,Dayal S. The role of platelet-derived extracellular vesicles in immune-mediated thrombosis Int J Mol Sci 2022 23 7837 PMC9320310

[15] Spakova T,Janockova J,Rosocha J. Characterization and therapeutic use of extracellular vesicles derived from platelets Int J Mol Sci 2021 22 9701 PMC8468534

[16] Trino S,Lamorte D,Caivano A,De Luca L,Sgambato A,Laurenzana I. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy Leukemia 2021 35 661 78 PMC7932927

[17] Lee SS,Won JH,Lim GJ.et al. A novel population of extracellular vesicles smaller than exosomes promotes cell proliferation Cell Commun Signal 2019 17 95 PMC6694590

[18] Davies R,Allen S,Mennan C,Platt M,Wright K,Kehoe O. Extracellular vesicle depletion protocols of foetal bovine serum influence umbilical cord mesenchymal stromal cell phenotype, immunomodulation, and particle release Int J Mol Sci 2023 24 9242 PMC10252846

[19] Sanchez-Manas JM,Perales S,Martinez-Navajas G.et al. Proteomic validation of MEG-01-derived extracellular vesicles as representative models for megakaryocyte- and platelet-derived extracellular vesicles Biomolecules 2025 15 1698 PMC12730508

[20] Van Deun J,Mestdagh P,Sormunen R.et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling J Extracell Vesicles 2014 3 24858 PMC4169610

[21] Garcia-Martin R,Brandao BB,Thomou T,Altindis E,Kahn CR. Tissue differences in the exosomal/small extracellular vesicle proteome and their potential as indicators of altered tissue metabolism Cell Rep 2022 38 110277 PMC8867597

[22] Kumar MA,Baba SK,Sadida HQ.et al. Extracellular vesicles as tools and targets in therapy for diseases Signal Transduct Target Ther 2024 9 27 PMC10838959

[23] Luo X,Jean-Toussaint R,Sacan A,Ajit SK. Differential RNA packaging into small extracellular vesicles by neurons and astrocytes Cell Commun Signal 2021 19 75 PMC8272329

[24] Eguchi A,Fukuda S,Kuratsune H.et al. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome Brain Behav Immun 2020 84 106 14 PMC7010541

[25] Holliday LS, Faria LP, Rody WJ Jr. Actin and actin-associated proteins in extracellular vesicles shed by osteoclasts Int J Mol Sci 2019 21 158 PMC6981389

[26] Butler JT,Abdelhamed S,Kurre P. Extracellular vesicles in the hematopoietic microenvironment Haematologica 2018 103 382 94 PMC5830368

[27] Huang Z,Zhuang Y,Li W.et al. Apoptotic vesicles are required to repair DNA damage and suppress premature cellular senescence J Extracell Vesicles 2024 13 e12428 PMC10997816

[28] He F,Laranjeira AB,Kong T.et al. Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms J Clin Invest 2024 134 e172256 PMC10836808